The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
HHS is soliciting input and will meet with vendors Aug. 7-8 to spur innovation in developing new technologies and products to save lives and improve health…
Headline
The Centers for Disease Control and Prevention is working with the U.S. Embassy in the Democratic Republic of the Congo to preposition staff in Goma to rapidly…
Headline
The World Health Organization today declared the Ebola virus disease outbreak in the Democratic Republic of the Congo a public health emergency of…
Headline
The Centers for Medicare…
Headline
CMS anticipates releasing later this summer the feedback it received on potential methodology changes to the overall hospital quality star ratings, the agency…
Headline
The Health Resources and Services Administration yesterday recognized 10 states whose critical access hospitals had the highest quality reporting rates and…